Sushant Vinarkar - Department of Laboratory Haematology and Molecular Genetics, Tata Medical Center

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P-181 Implementation of a Stepwise Systematic FISH Strategy in Identifying Clinically Relevant Cytogenetic Abnormalities in Plasma Cell Neoplasms in Resource Constraint Settings

Mayur Parihar,Aaishwarya Dhabe, Siprarani Patel, Pranay Gurung, Samipa Das, Prahar Dahal,Asish Rath,Sushant Vinarkar,Shouriyo Ghosh,Dibakar Podder, Debaranjini Chattopadhay,Arijit Nag, Jeevan Garg, Reena Nair,Deepak Mishra

Clinical Lymphoma Myeloma and Leukemia (2024): S142-S143

引用0浏览0引用

Current Diagnosis of Bleeding Disorders in Lower Income Countries

Deepak K Mishra, Asish Rath,Mayur Parihar,Sushant S Vinarkar, Anirban Kundu

International journal of laboratory hematology (2024)

引用0浏览0WOS引用

Clinicopathological Profile of Acute Myeloid Leukemias with Myelodysplasia-Related Mutations

Prakhar Gupta, Sabyasachi Roy, Ashish Rath,Kallol Saha, Saheli Banerjee, Debjani Nathni,Sushant Vinarkar,Mayur Parihar,Deepak K. Mishra

JOURNAL OF MOLECULAR DIAGNOSTICSno. 6 (2024): S17-S18

引用0浏览0引用

P-185 Single Tube Twelve Color Flow Cytometric Myeloma MRD Assay- A Single-Center Experience from Eastern India

Asish Rath, Pratyush Mishra,Sushant Vinarkar, Munmun Banerjee,Sambhunath Banerjee,Subhajit Brahma,Arijit Nag,Debranjani Chattopadhyay,Dibakar Podder,Jeevan Kumar, Reena Nair,Mayur Parihar,Deepak Kumar Mishra

Clinical Lymphoma Myeloma and Leukemia (2024): S145

引用0浏览0引用

AML-454 Outcomes of Azacytidine-Venetoclax Therapy in Upfront and Relapsed/refractory Setting in Acute Myeloid Leukemia: Real World Experience from India

Shouriyo Ghosh,Subir Sinha, Sutapa Chatterjee,Arijit Nag,Debranjani Chattopadhyay,Dibakar Podder,Jeevan Kumar,Rizwan Javed,Asish Rath,Deepak Mishra,Sushant Vinarkar,Mayur Parihar, Reena Nair

Clinical Lymphoma Myeloma & Leukemia (2024): S314-S314

引用0浏览0引用

Early Impressions with Use of BCMA-Directed Therapy: Elranatamab in Multiply Relapsed/Refractory Multiple Myeloma: A Safety and Efficacy Analysis in a Tertiary Cancer Center in India

Dibakar Podder, Noopur Patil, Anupam Brahma,Sundar Shewale,Rizwan Javed,Debranjani Chattopadhyay,Shouriyo Ghosh,Arijit Nag,Jeevan Kumar, Ashish Rath,Sushant Vinarkar,Mayur Parihar,Deepak Mishra,Subhosmito Chakraborty, Reena Nair

Clinical Lymphoma Myeloma & Leukemia (2024): S239-S239

引用0浏览0引用

Bortezomib-Pomalidomide-Dexamethasone (VPD) As Novel Induction Therapy in Newly-Diagnosed Multiple Myeloma: Early Safety Data from an Ongoing Single Arm Phase-II Investigator-Initiated Clinical Trial (PRIME Study)

Vivek S. Radhakrishnan,Naveed Tamboli, Shreya Das,Jeevan Kumar Garg,Arijit Nag,Saurabh J. Bhave,Mayur Parihar,Sushant Vinarkar,Sumit Mukhopadhyay,Subhosmito Chakraborty,Deepak K. Mishra,Reena Nair,Mammen Chandy

Bloodno. Supplement 1 (2023): 6713-6713

引用1浏览0引用

Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future

Deepak Kumar Mishra, Indranil Dey, Rakesh Demde,Sushant Vinarkar,Mayur Parihar

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGYno. 06 (2023): 592-601

引用0浏览0引用

Pb2223: clinicopathological, cytogenetic and molecular characteristics of patients with non-cml myeloproliferative neoplasms: a single center study

Vinay Anand Guntiboina,Arijit Nag,Jeevan Kumar,Sushant Vinarkar, Ashish Rath,Saurabh Jayant Bhave,Vivek Radhakrishnan,Deepak Kumar Mishra,Reena Nair,Mammen Chandy

HemaSphereno. S3 (2023): e8162334-e8162334

引用0浏览0引用

Peripheral T-cell lymphoma, hemophagocytic lymphohistiocytosis and XIAP gene mutations: getting the treatment right

Vinay Anand Guntiboina,Vivek S Radhakrishnan,Jeevan Kumar,Saurabh J Bhave,Sushant Vinarkar,Jayanta Das,Indu Arun,Deepak Kumar Mishra,Mammen Chandy,Reena Nair

Clinical Lymphoma, Myeloma & Leukemia（2022）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn